SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 33 filers reported holding SQZ BIOTECHNOLOGIES CO in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $111,474 | -53.9% | 412,865 | -4.3% | 0.00% | -50.0% |
| Q1 2023 | $241,584 | -24.3% | 431,400 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $319,236 | -67.6% | 431,400 | 0.0% | 0.00% | -83.3% |
| Q3 2022 | $984,000 | -28.3% | 431,400 | 0.0% | 0.01% | -71.4% |
| Q2 2022 | $1,372,000 | – | 431,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |